Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Post-approval studies (Phase 4)Study completedNCT00282932
What this trial is testing

Detrol LA In Men With Overactive Bladder.

Who this might be right for
Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Post-approval studies (Phase 4)Study completedNCT00333112
What this trial is testing

Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

Who this might be right for
Urinary Incontinence
Astellas Pharma Inc 398
Large-scale testing (Phase 3)WithdrawnNCT01003405
What this trial is testing

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Who this might be right for
Overactive Bladder
Kissei Pharmaceutical Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT00662909
What this trial is testing

Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,149
Testing effectiveness (Phase 2)Study completedNCT00742833
What this trial is testing

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)
Kissei Pharmaceutical Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT00689104
What this trial is testing

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,336
Not applicableStudy completedNCT01369485
What this trial is testing

Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder

Who this might be right for
Overactive Bladder
Ethicon Endo-Surgery 163
Post-approval studies (Phase 4)Study completedNCT00547378
What this trial is testing

InSite for Over Active Bladder

Who this might be right for
Urinary Incontinence, Urgency-frequencyOveractive Bladder
MedtronicNeuro 571
Large-scale testing (Phase 3)Study completedNCT01004315
What this trial is testing

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Who this might be right for
Overactive Bladder
Kissei Pharmaceutical Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT01908829
What this trial is testing

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder OveractiveUrologic Diseases
Astellas Pharma Europe Ltd. 2,174
Not applicableWithdrawnNCT03019094
What this trial is testing

Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1

Who this might be right for
Overactive Bladder
BlueWind Medical
Post-approval studies (Phase 4)Study completedNCT00230789
What this trial is testing

Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

Who this might be right for
Urinary Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 417
Not applicableStudy completedNCT01125722
What this trial is testing

Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)

Who this might be right for
Overactive Bladder
Ethicon Endo-Surgery 74
Not applicableNot Yet RecruitingNCT06659536
What this trial is testing

Cefar URO - Symptomatic Treatment of Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)Refractory Overactive BladderUrinary Urgency and Frequency
DJO UK Ltd 53
Not applicableLooking for participantsNCT06091566
What this trial is testing

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

Who this might be right for
Urinary IncontinenceUrinary Incontinence, UrgeFecal Incontinence+5 more
InnoCon Medical 20
Not applicableLooking for participantsNCT06754189
What this trial is testing

Safety and Performance of UCon Patch Electrode

Who this might be right for
Urinary IncontinenceUrinary Incontinence, UrgeNocturia+5 more
InnoCon Medical 180
Not applicableStudy completedNCT03520166
What this trial is testing

Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain

Who this might be right for
Urinary Bladder, OveractiveLower Urinary Tract SymptomsPelvic Pain
Fisioterapia Pélvica Avanzada Madrid, SRL 100
Not applicableEnded earlyNCT04831801
What this trial is testing

OAB and the Microbiome

Who this might be right for
Overactive BladderUrgency-frequency Syndrome
University of Miami 39
Early research (Phase 1)Study completedNCT01286454
What this trial is testing

This Is A Study Of Bioavailability And Food Effect For Fesoterodine.

Who this might be right for
Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT01638000
What this trial is testing

Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

Who this might be right for
Urologic DiseasesUrinary Bladder, OveractiveUrinary Bladder Diseases
Astellas Pharma Europe Ltd. 1,887